Table 1.
Summary of the GWAS datasets used in the current study
| Phenotype | N cases | N controls | N total | N effective a | GWAS genome-wide significant SNPsb | References |
|---|---|---|---|---|---|---|
| IBS | 53,400 | 433,201 | 486,601 | 190,159 | 6 | [18] |
| Neuroticism | – | – | 390,278c | 390,278 | 136d | [20] |
| Depression | 170,756 | 329,443 | 500,199c | 449,856 | 102d | [21] |
| Anxiety nerves or GAD | 16,730 | 101,021 | 117,751 | 57,412 | 1 | UKBB phenotype code: 20544_15 |
GAD generalized anxiety disorder; UKBB UK Biobank
aN effective sample sizes were calculated following the equation: Neff = 4/(1/Ncases + 1/Ncontrols)
bNumber of genome-wide significant independent SNPs
cSample size excluding the 23andMe cohort
dGenome-wide significant SNPs including the 23andMe cohort